Circle Cardiovascular Imaging, Inc.: Series B $3.9M

Posted in I - Series B, Q - 3Q11, R - INTERNATIONAL, X - Imaging, X - TeleMedicine

Circle Cardiovascular Imaging (Canada) a commercial-stage analytical software company focused on cardiac imaging, closed a $3.9M Series B financing. Participants include Business Development Bank of Canada, Foundation Equity and First Yellowhead Equities.
Thanx for your patience as we catch-up.

DICOM Grid, Inc.: Series A $7.5M

Posted in I - Series A, Q - 4Q10, R - SOUTH WEST, X - Bioinformatics, X - Imaging, X - TeleMedicine, XX - AZ

DICOM Grid (Phoenix, AZ) a development-stage bioinformatics company focused on the development of medical imaging software, closed a $7.5M Series A financing. Participants include Canaan Partners and CHL Medical Partners.

Marval Biosciences, Inc.: Series B $2.5M

Posted in I - Series B, Q - 4Q09, R - WEST, X - Imaging, XX - CA

Marval Biosciences (San Diego, CA) a preclinical-stage biopharma company focused on the reformulation of contrast dyes for CT scans using liposomal nanoparticles, closed a $2.5M Series B financing. Participants include DFJ Frontier and DFJ Mercury.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

Avid Radiopharmaceuticals, Inc.: Series D $34.5M

Posted in I - Series D, Q - 2Q09, R - NORTH EAST, X - Alzheimer's, X - Dementia, X - Diabetes, X - Imaging, X - Parkinson's, XX - PA

Avid Radiopharmaceuticals (Philadelphia, PA) a development-stage company focused on molecular imaging compounds for diagnostic and detection use in Alzheimer’s, dementia, Parkinson’s and diabetes, closed a $24.5M Series D financing. Participants include Alta Partners, AllianceBernstein, Safeguard Scientifics, Pfizer Venture Investments, Lilly Ventures, RK Ventures Group and BioAdvance.

Rcadia Medical Imaging, Ltd. Series B $3.3M

Posted in I - Series B, Q - 4Q08, R - INTERNATIONAL, X - Bioinformatics, X - Cardiology, X - Device (Imaging), X - Imaging

Rcadia Medical Imaging (Israel) developer of image processing based software products for blood vessel analysis closed a $3.3M Series B financing. Participants include BioVentures Investors and 20/20 HealthCare Partners.

Orthoscan, Inc.: Series B $7.5M

Posted in I - Series B, Q - 4Q08, R - SOUTH WEST, X - Imaging, X - Orthopedic

Orthoscan (Scottsdale, AZ) developer of medical device imaging products with a focus on orthopaedics, closed a $7.5M Series B financing. Participants include River Cities Capital Funds, Aphelion Capital and California Technology Ventures.

BioImagene, Inc.: Series D $26M

Posted in I - Series D, Q - 3Q08, R - WEST, X - Device (Diagnostic), X - Imaging

BioImagene (Cupertino, CA) commercial-stage provider of digital pathology solutions for cancer diagnosis and preclinical research, closed a $26M Series D financing. Participants include Burrill & Co., Ascension Health Ventures, National Healthcare Services, Artiman Ventures and ICCP Ventures.

Celleration, Inc.: Series D $30M

Posted in I - Series D, Q - 3Q08, R - MID WEST, X - Device (Imaging), X - Imaging, X - Wound Healing

Celleration (Eden Prairie, MN) commercial-stage medical device company focused on non-contact ultrasound device for wound care, closed a $25M Series D financing. Participants include Venture Investors, Upper Lake Growth Capital, Baird Venture Partners, Aavin Equity Advisors, Triathlon Medical Ventures and New Science Ventures.

HyperMed, Inc.: Series B $4M

Posted in I - Series B, Q - 2Q08, R - NORTH EAST, X - Imaging

HyperMed (Burlington, MA) early-stage company focused on hyperspectral medical imaging, closed a $4M Series B financing. Participants include GBP Capital.

VisEn Medical, Inc.: Series B $12M

Posted in I - Series B, Q - 2Q08, R - NORTH EAST, X - Biomarker, X - Imaging, X - Reagent

VisEn Medical (Woburn, MA) commercial-stage company focused on fluorescence in vivo imaging, closed a $5M Series B financing. Participants include Merck Capital Ventures and Flagship Ventures.

Micrima Ltd.: Series A $3.5M

Posted in I - Series A, Q - 2Q08, R - INTERNATIONAL, X - Device (Diagnostic), X - Imaging, X - Oncology

Micrima (England) early-stage stage company focused on the radio wave technology to improve detection of breast cancer, closed a $3.5M Series A financing. Participants include YFM Group, Swarraton Partners and Nesta.

to top of page...